SEC Tracker
Get the app

Sangamo Therapeutics SGMOQ

Sangamo Therapeutics delisted

Delisting notice

Form
25-NSE
Filed
Importance
Notable
  1. Form 25-NSE filed on Oct 7, 2026
  2. Delisted effective Oct 16, 2026
  3. Nasdaq determined non-compliance with Listing Rule 5,550(a)(2)
  4. Appeal denied on Jul 13, 2026

Written from the 25-NSE on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sangamo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Monopar Therapeutics MNPR public float $156M, Jun 30, 2025
  2. Alpha Cognition ACOG public float $149M, Jun 30, 2025
  3. Aclaris Therapeutics ACRS public float $149M, Jun 30, 2025
  4. Forte Biosciences FBRX public float $157M, Jun 30, 2025
  5. Neurogene NGNE public float $146M, Jun 30, 2025